01Jul
Novartis and Alcon FCPA Enforcement Action: Lessons Learned (Part III of III)
At the outset, Novartis is “lucky” – the settlement is relatively positive, despite its 2016 SEC enforcement action in China. Given Novartis weak culture of compliance (if anything, a better description may be a culture of non-compliance) and its status as a recidivist, Novartis could have been slammed with a stiffer enforcement action, including assignment of an independent corporate compliance monitor and a higher penalty. ...
By:
Michael Volkov
Related
On July 1, 2019, Chapter 558, Florida Statutes, will be amended to add section 558.004(1)(d), which ...
Read More >
Preserving privilege with respect to pre-closing communications between a selling corporation’s cou...
Read More >
New York Governor Andrew Cuomo has signed into law amendments to the New York State Human Rights Law...
Read More >
In September 2019, Seattle City Council voted to adopt a series of ordinances aimed at protecting ho...
Read More >
As 2019 comes to an end, we are pleased to present our traditional End of Year Plan Sponsor “To Do”...
Read More >
Washington’s Department of Labor and Industries just decided to substantially raise the state’s sa...
Read More >